Interestingly, in a colon cancer mouse model, the immune-suppressive effect of TGF-β1 has been shown to be involved in repression of CXCL9 and CXCL10 expression in CAFs, which subsequently inhibited the recruitment of effector T cell infiltration into tumors [34]. Here, TGFB1 is linked to colonic neoplasm.